Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Cystatin C Tracks Renal Function Decline in Diabetes
Link ID 5716
Title Cystatin C Tracks Renal Function Decline in Diabetes
Url http://www.medscape.com/viewarticle/574374?src=rss
Description Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in patients with type 1 diabetes, Australian researchers report in the May issue of Diabetes Care. Reuters Health Information
Category Articles > Diabetes and Endocrinology
Keywords
Date May 14, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Diabetes and Endocrinology
1. Etanercept Improves Growth in Children With Arthritis
  Anti-tumor necrosis factor (TNF) treatment with etanercept improves longitudinal growth in prepubertal and pubertal children with juvenile idiopathic arthritis (JIA), according to Scandinavian researchers. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


2. Synergistic Effect of Statins and Postmenopausal Hormone Therapy in the Prevention of Skeletal Fract
  Does this benefit only extend to statin users who currently take hormonal therapy? Pharmacotherapy
Category:   Articles > Diabetes and Endocrinology


3. Aerobic Exercise Boosts Peripheral Insulin Sensitivity in Type 2 Diabetics
  The improvement in whole-body insulin sensitivity seen in type 2 diabetics who engage in aerobic exercise is due to gains in peripheral, not hepatic, insulin sensitivity, study findings indicate. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


4. Early Weight Gain Tied to Diabetes Risk in Children
  In certain children with a family history of type 1 diabetes, weight gain in early life predicts the risk of islet autoimmunity, Australian researchers report in the January issue of Diabetes Care. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


5. Zoledronic Acid Infusion Effective for Bone Loss Linked With Glucocorticoid Use
  In a randomized trial, a single 5-mg intravenous infusion of zoledronic acid was more acceptable to patients vs 5 mg of oral risedronate daily to prevent and treat glucocorticoid-related bone loss. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS